Article
At-line Spent Media Analysis using the REBEL to Optimize a CHO mAb Fed-Batch Process
Author(s):
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
